Selective inhibitors nonsteroidal anti inflammatory aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cells, Cultured Blood Platelets Gastric Mucosa Cell Line, Tumor Tumor Cells, Cultured Cell Line Microsomes, Liver Endothelium, Vascular Kidney

Organisms8

Rats, Wistar Rats, Sprague-Dawley Tropaeolaceae Rabbits Mice, Inbred C57BL Dogs Cattle Mice, Inbred BALB C

Diseases29

Stomach Ulcer Gastrointestinal Diseases Gastrointestinal Hemorrhage Drug Hypersensitivity Asthma, Aspirin-Induced Peptic Ulcer Hemorrhage Osteoarthritis Peptic Ulcer Arthritis Colonic Neoplasms Hemorrhage Disease Models, Animal Pain Colorectal Neoplasms Myocardial Infarction Inflammation Edema Adenomatous Polyps Ulcer Stomach Diseases Thrombosis Cardiovascular Diseases Kidney Papillary Necrosis Duodenal Ulcer Arthritis, Rheumatoid Adenoma Adenomatous Polyposis Coli Reye Syndrome Stroke

Chemicals and Drugs144

Aspirin Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Ibuprofen Prostaglandin-Endoperoxide Synthases Diclofenac Naproxen Cyclooxygenase 2 Cyclooxygenase 1 Platelet Aggregation Inhibitors Sulfonamides Pyrazoles Sulindac Indomethacin Flurbiprofen Enzyme Inhibitors Piroxicam Isoenzymes Sulfones Nitrobenzenes Thromboxane B2 Acetaminophen Ketoprofen Salicylates Dinoprostone Etodolac Tolmetin Lactones Sodium Salicylate Thiazines Ticlopidine Prostaglandins Ketorolac Phenylbutazone Anti-Inflammatory Agents Growth Differentiation Factor 15 Cyclic Nucleotide Phosphodiesterases, Type 4 Rolipram Membrane Proteins Phosphodiesterase Inhibitors Analgesics, Non-Narcotic Fenoprofen Arachidonic Acid 3',5'-Cyclic-AMP Phosphodiesterases Analgesics Lipoxygenase Inhibitors Thiazoles Antineoplastic Agents 6-Ketoprostaglandin F1 alpha Anticarcinogenic Agents Pyridines Indoles Thromboxanes Diflunisal Nitric Oxide Isoxazoles Thromboxane A2 Warfarin Anticoagulants Epoprostenol Nitriles Oxyphenbutazone Nonsteroidal Anti-Androgens Fibrinolytic Agents Prostaglandin Antagonists Nitric Oxide Synthase Indazoles Clonixin Amidines Protein Kinase Inhibitors Lipoxins Butanones Imidazoles Propionates RNA, Messenger Heterocyclic Compounds, 2-Ring Tablets, Enteric-Coated Arachidonic Acids Nitric Oxide Donors Nitric Oxide Synthase Type II Triazoles Salicylic Acid Anilides Phenylpropionates Recombinant Proteins Aromatase Inhibitors Carrageenan Mefenamic Acid Ketorolac Tromethamine ortho-Aminobenzoates Flutamide Phospholipase A2 Inhibitors Estrogen Antagonists Anti-Ulcer Agents Cyclic Nucleotide Phosphodiesterases, Type 1 Fenamates Piperazines Pyrrolidinones Antibodies, Monoclonal Proton Pump Inhibitors Protein Kinase C Pyrimidines Oxadiazoles Eicosanoids Cytochrome P-450 Enzyme System Hydroxyprostaglandin Dehydrogenases Hydroxyeicosatetraenoic Acids Dipyridamole Indoprofen Benzamides Guanidines DNA Suprofen Amides Phosphodiesterase 4 Inhibitors Thromboxane-A Synthase Ethamoxytriphetol Protease Inhibitors Tumor Necrosis Factor-alpha Cyclic GMP Cyclic Nucleotide Phosphodiesterases, Type 3 p38 Mitogen-Activated Protein Kinases Prostaglandins E Adenine Misoprostol Isothiuronium Adamantane Benzopyrans Mitogen-Activated Protein Kinases Histamine H2 Antagonists Thiophenes Androstadienes 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)Lipopolysaccharides Calcium Sulfinpyrazone Plant Extracts Thiourea Flufenamic Acid Maleimides Heparin Nitric Oxide Synthase Type I Antiviral Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Drug Therapy, Combination Models, Molecular Platelet Function Tests Risk Factors Double-Blind Method Drug Design Treatment Outcome Administration, Oral Chemoprevention Inhibitory Concentration 50 Prospective Studies Magnetic Resonance Spectroscopy Blotting, Western Drug Evaluation, Preclinical Crystallography, X-Ray Case-Control Studies Disease Models, Animal Chromatography, High Pressure Liquid Bleeding Time Drug Administration Schedule Randomized Controlled Trials as Topic Follow-Up Studies Risk Cohort Studies Incidence Risk Assessment Odds Ratio Reverse Transcriptase Polymerase Chain Reaction Immunohistochemistry Enzyme-Linked Immunosorbent Assay Clinical Trials as Topic Cross-Over Studies Retrospective Studies

Psychiatry and Psychology1

Phenomena and Processes33

Dose-Response Relationship, Drug Platelet Aggregation Molecular Structure Stereoisomerism Drug Interactions Time Factors Structure-Activity Relationship Kinetics Apoptosis Inhibitory Concentration 50 Molecular Conformation Signal Transduction Enzyme Activation Phosphorylation Platelet Activation Binding Sites Cell Proliferation Drug Synergism Pain Bleeding Time Cell Survival Amino Acid Sequence Risk Substrate Specificity Drug Resistance Catalytic Domain Nucleic Acid Conformation Cell Division Odds Ratio Protein Binding Hydrogen Bonding Enzyme Induction Base Sequence

Disciplines and Occupations2

Drug Design Immunohistochemistry

Information Science4

Molecular Sequence Data Amino Acid Sequence Incidence Base Sequence

Health Care15

Risk Factors Double-Blind Method Treatment Outcome Prospective Studies Case-Control Studies Randomized Controlled Trials as Topic Follow-Up Studies Risk Cohort Studies Incidence Risk Assessment Odds Ratio Clinical Trials as Topic Cross-Over Studies Retrospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Health Care

Aspirin Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Ibuprofen Prostaglandin-Endoperoxide Synthases Diclofenac Naproxen Cyclooxygenase 2 Cyclooxygenase 1 Platelet Aggregation Inhibitors Sulfonamides Pyrazoles Sulindac Indomethacin Flurbiprofen Enzyme Inhibitors Piroxicam Dose-Response Relationship, Drug Isoenzymes Sulfones Nitrobenzenes Thromboxane B2 Acetaminophen Ketoprofen Salicylates Dinoprostone Etodolac Tolmetin Lactones Sodium Salicylate Thiazines Platelet Aggregation Molecular Structure Stomach Ulcer Gastrointestinal Diseases Ticlopidine Drug Therapy, Combination Prostaglandins Stereoisomerism Gastrointestinal Hemorrhage Drug Interactions Ketorolac Models, Molecular Phenylbutazone Anti-Inflammatory Agents Time Factors Growth Differentiation Factor 15 Cyclic Nucleotide Phosphodiesterases, Type 4 Rolipram Cells, Cultured Blood Platelets Membrane Proteins Structure-Activity Relationship Phosphodiesterase Inhibitors Analgesics, Non-Narcotic Platelet Function Tests Gastric Mucosa Risk Factors Fenoprofen Rats, Wistar Double-Blind Method Arachidonic Acid Drug Hypersensitivity 3',5'-Cyclic-AMP Phosphodiesterases Rats, Sprague-Dawley Kinetics Analgesics Cell Line, Tumor Apoptosis Drug Design Lipoxygenase Inhibitors Asthma, Aspirin-Induced Thiazoles Antineoplastic Agents Treatment Outcome 6-Ketoprostaglandin F1 alpha Administration, Oral Anticarcinogenic Agents Pyridines Peptic Ulcer Hemorrhage Chemoprevention Indoles Inhibitory Concentration 50 Molecular Conformation Thromboxanes Diflunisal Nitric Oxide Signal Transduction Isoxazoles Tropaeolaceae Osteoarthritis Thromboxane A2 Prospective Studies Warfarin Anticoagulants Epoprostenol Magnetic Resonance Spectroscopy Nitriles Oxyphenbutazone

No FAQ available that match "selective inhibitors nonsteroidal anti inflammatory aspirin"